News Detail
London, 11 Oct 2023: Researchers have developed a new blood test that detects early stage ovarian cancer and may determine whether a pelvic mass is benign or cancerous with 91 per cent accuracy, a rate better than existing tests.
The test known as OvaPrint ......
View Details
Source : IANS & DrugsControl Media Services
methylation
HGSOC
ovarian cancer
ovaprint
bodour salhia
health news
Blood
Blood Test
Cancer
Biopsy
Biotechnology
Carcinoma
Cell
CpG
Diagnostic
Diagnostics
DNA
DNA Methylation
Genomic
Genomics
Medicine
Oncology
Preclinical
Research
Surgery
Related News
- Researchers develop a better way to deliver long-lasting drugs (25-03-2025)
- Pioneer groundbreaking light-driven method to create key drug compounds (24-03-2025)
- Mandimycin: A polyene antifungal with a unique mode of action (22-03-2025)
- Newly identified bacterial protein helps design cancer drug delivery system (21-03-2025)
- IIT Roorkee researchers identify a potential drug against Chikungunya (18-03-2025)
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)